These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 17662129

  • 1. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials.
    McKenna SP, Doward LC, Meads DM, Tennant A, Lawton G, Grueger J.
    Health Qual Life Outcomes; 2007 Jul 27; 5():45. PubMed ID: 17662129
    [Abstract] [Full Text] [Related]

  • 2. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar 27; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 3. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
    Sunderkötter C, Weiss JM, Bextermöller R, Löffler H, Schneider D.
    J Dtsch Dermatol Ges; 2006 Apr 27; 4(4):301-6. PubMed ID: 16638059
    [Abstract] [Full Text] [Related]

  • 4. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
    Beattie PE, Lewis-Jones MS.
    Br J Dermatol; 2006 Dec 27; 155(6):1249-55. PubMed ID: 17107397
    [Abstract] [Full Text] [Related]

  • 5. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR, Martin JA, Finlay AY.
    Am J Clin Dermatol; 2009 Dec 27; 10(4):229-37. PubMed ID: 19489656
    [Abstract] [Full Text] [Related]

  • 6. Quality of life of children with atopic dermatitis and their families.
    McKenna SP, Doward LC.
    Curr Opin Allergy Clin Immunol; 2008 Jun 27; 8(3):228-31. PubMed ID: 18560297
    [Abstract] [Full Text] [Related]

  • 7. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec 27; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 8. The DISABKIDS generic quality of life instrument showed cross-cultural validity.
    Schmidt S, Debensason D, Mühlan H, Petersen C, Power M, Simeoni MC, Bullinger M, European DISABKIDS Group.
    J Clin Epidemiol; 2006 Jun 27; 59(6):587-98. PubMed ID: 16713521
    [Abstract] [Full Text] [Related]

  • 9. Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD).
    Kondo-Endo K, Ohashi Y, Nakagawa H, Katsunuma T, Ohya Y, Kamibeppu K, Masuko I.
    Br J Dermatol; 2009 Sep 27; 161(3):617-25. PubMed ID: 19438436
    [Abstract] [Full Text] [Related]

  • 10. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).
    Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ, Frech F, Van Assche D.
    Br J Dermatol; 2004 Feb 27; 150(2):274-83. PubMed ID: 14996098
    [Abstract] [Full Text] [Related]

  • 11. An international scoring system for self-reported health complaints in adolescents.
    Ravens-Sieberer U, Erhart M, Torsheim T, Hetland J, Freeman J, Danielson M, Thomas C, HBSC Positive Health Group.
    Eur J Public Health; 2008 Jun 27; 18(3):294-9. PubMed ID: 18252752
    [Abstract] [Full Text] [Related]

  • 12. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.
    Br J Dermatol; 2009 Feb 27; 160(2):415-22. PubMed ID: 19067708
    [Abstract] [Full Text] [Related]

  • 13. Internal construct validity of the Oxford Knee Scale: evidence from Rasch measurement.
    Conaghan PG, Emerton M, Tennant A.
    Arthritis Rheum; 2007 Dec 15; 57(8):1363-7. PubMed ID: 18050174
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Bernard LA, Bergman JN, Eichenfield LF.
    Skin Therapy Lett; 2002 Apr 15; 7(4):1-3. PubMed ID: 12097994
    [Abstract] [Full Text] [Related]

  • 15. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M, Garside R, Stein K.
    Br J Dermatol; 2006 Jun 15; 154(6):1137-46. PubMed ID: 16704646
    [Abstract] [Full Text] [Related]

  • 16. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness.
    Chamlin SL, Lai JS, Cella D, Frieden IJ, Williams ML, Mancini AJ, Chren MM.
    Arch Dermatol; 2007 Jun 15; 143(6):768-72. PubMed ID: 17576944
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
    Giordano-Labadie F, Cambazard F, Guillet G, Combemale P, Mengeaud V.
    J Dermatolog Treat; 2006 Jun 15; 17(2):78-81. PubMed ID: 16766330
    [Abstract] [Full Text] [Related]

  • 18. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
    De Backer M, Morren MA, Boonen H, Boyden B, Vertruyen A, Lecomte P, Paquay C, Lesaffre E, Lambert J.
    Dermatology; 2008 Jun 15; 217(2):156-63. PubMed ID: 18525202
    [Abstract] [Full Text] [Related]

  • 19. A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a rheumatoid arthritis population using Rasch analysis.
    Covic T, Pallant JF, Conaghan PG, Tennant A.
    Health Qual Life Outcomes; 2007 Jul 13; 5():41. PubMed ID: 17629902
    [Abstract] [Full Text] [Related]

  • 20. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.
    J Am Acad Dermatol; 2009 Feb 13; 60(2):212-7. PubMed ID: 19027990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.